Literature DB >> 7578179

Proposal of a working left heart model with a heterotopic transplantation technique in rats.

H Yokoyama1, M Ohmi, S Murata, T Nakame, K Tabayashi, H Mohri.   

Abstract

BACKGROUND: A heterotopically transplanted rat heart model described by Ono and Lindsey in 1969 has been widely used as a fundamental animal model of heart transplantation. However this "nonworking" model is greatly different from the orthotopic heart in view of left ventricular work, in which the experimental results obtained may not always reflect the clinical setting with an orthotopic transplanted "working" heart. We herein propose a new "working" left heart model in rats using a heterotopic abdominal transplantation technique by modifying the method of Ono and Lindsey.
METHODS: First, a donor heart graft and a recipient were prepared in the conventional fashion. Second, the donor heart was tailored by the ligation of main pulmonary artery and the removal of tricuspid valve and interatrial septum. Third, the ascending aorta and right atrium of the donor heart were anastomosed to the infrarenal abdominal aorta and to the inferior vena cava of the recipient, respectively. Consequently, the left atrium and ventricle of heart graft were loaded with the blood from the right atrium through the interatrial communication.
RESULTS: This surgical procedure required an average of 58 minutes and had negligible operative risk. The donor left ventricle produced a systolic blood pressure almost equal to the recipient's aortic pressure and maintained vigorous beat.
CONCLUSIONS: This model is easily reproducible and would be useful for various studies on heart transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7578179

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

1.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

Authors:  Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

2.  Rat Heterotopic Abdominal Heart/Single-lung Transplantation in a Volume-loaded Configuration.

Authors:  Mark J Kearns; Yingjin Wang; John H Boyd
Journal:  J Vis Exp       Date:  2015-05-29       Impact factor: 1.355

3.  Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.

Authors:  Marcus Franz; K Grün; P Richter; B R Brehm; M Fritzenwanger; K Hekmat; D Neri; J Gummert; H R Figulla; H Kosmehl; A Berndt; A Renner
Journal:  Histochem Cell Biol       Date:  2010-10-08       Impact factor: 4.304

4.  Optimized protocol for immunostaining of experimental GFP-expressing and human hearts.

Authors:  Tania Zaglia; Anna Di Bona; Tatiana Chioato; Cristina Basso; Simonetta Ausoni; Marco Mongillo
Journal:  Histochem Cell Biol       Date:  2016-06-17       Impact factor: 4.304

5.  Host-based Th2 cell therapy for prolongation of cardiac allograft viability.

Authors:  Shoba Amarnath; Hao Chen; Jason E Foley; Carliann M Costanzo; Joel D Sennesh; Michael A Solomon; Daniel H Fowler
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Serological cytokine profiles of cardiac rejection and lung infection after heart transplantation in rats.

Authors:  Hao Chen; Juhua Yang; Shengchao Zhang; Xuan Qin; Wei Jin; Lihua Sun; Feng Li; Yunfeng Cheng
Journal:  J Cardiothorac Surg       Date:  2019-01-29       Impact factor: 1.637

7.  Impact of animal strain on gene expression in a rat model of acute cardiac rejection.

Authors:  Katherine J Deans; Peter C Minneci; Hao Chen; Steven J Kern; Carolea Logun; Sara Alsaaty; Kelly J Norsworthy; Stephanie M Theel; Joel D Sennesh; Jennifer J Barb; Peter J Munson; Robert L Danner; Michael A Solomon
Journal:  BMC Genomics       Date:  2009-06-24       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.